SCHEMBL7357405

SCHEMBL7357405

CC(CC(=O)OC(=O)C(F)(F)F)N1C(=O)c2cc(CCCC(S)NC(=N)N)ccc2N(C)C(=O)C1c1ccccc1

nearest known ligand 0.32

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MDM2 Q00987 2/20 0.32
F2 P00734 2/20 0.30
ITGB3 P05106 2/20 0.30
ITGA2B P08514 2/20 0.30
F10 P00742 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7329938 0.93
SCHEMBL7332536 0.92 MDM2 (0.33) MDM2F2ITGB3ITGA2BF10
SCHEMBL7320396 0.92
SCHEMBL7331809 0.91 MDM2 (0.33) MDM2
SCHEMBL7332127 0.90 MDM2 (0.34) MDM2
SCHEMBL7324133 0.88 MDM2 (0.32) MDM2
SCHEMBL7325218 0.86 MDM2 (0.35) MDM2
SCHEMBL7324305 0.86
SCHEMBL7331835 0.85 SLC6A9 (0.34) MDM2
SCHEMBL7329505 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663166-A ANTICOAGULANTS OF 1,4-BENZODIAZEPINE-2,5-DIONE AND 2-BENZOAZEPINE-1,4-DIONE DERIVATIVES; PREVENTS FIBRINOGEN BINDING NECESSARY FOR PLATELET AGGREGATION; SIDE EFFECT REDUCTION, E.G. EXCESSIVE BLEEDING GENENTECH, INC. (US) 1997-09-02 US disclosed
EP-0610334-B1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPII B III A RECEPTOR GENENTECH INC (US) 1996-01-24 EP disclosed
US-5403836-A Anticoagulants GENENTECH, INC. (US) 1995-04-04 US disclosed
US-5250679-A Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor GENENTECH, INC. (US) 1993-10-05 US disclosed
WO-1993008174-A1 NONPEPTIDYL INTEGRIN INHIBITORS HAVING SPECIFICITY FOR THE GPIIbIIIa RECEPTOR GENENTECH, INC. (US) 1993-04-29 WO disclosed